Beauty Health Co
General ticker "SKIN" information:
- Sector: Consumer Staples
- Industry: Personal Care Products
- Capitalization: $184.2M
Beauty Health Co does not follow the US Stock Market performance with the rate: -19.8%.
Estimated limits based on current volatility of 4.7%: low 1.37$, high 1.51$
Factors to consider:
- US accounted for 66.5% of revenue in the fiscal year ended 2022-12-31
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.28$, 4.34$]
- 2024-12-30 to 2025-12-30 estimated range: [1.65$, 4.67$]
Financial Metrics affecting the SKIN estimates:
- Negative: Non-GAAP EPS, $ of 0.01 <= 0.10
- Negative: Operating profit margin, % of -24.75 <= 1.03
- Negative: negative Net income
- Positive: -0.96 < Investing cash flow per share, $ of -0.24
- Negative: Operating cash flow per share per price, % of 5.59 <= 7.18
- Negative: Industry operating cash flow per share per price (median), % of 3.20 <= 3.85
- Positive: Industry inventory ratio change (median), % of -1.65 <= -0.39
Short-term SKIN quotes
Long-term SKIN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $260.09MM | $365.88MM | $397.99MM |
| Operating Expenses | $296.73MM | $390.16MM | $528.91MM |
| Operating Income | $-36.64MM | $-24.28MM | $-130.92MM |
| Non-Operating Income | $-340.71MM | $69.31MM | $29.03MM |
| Interest Expense | $11.78MM | $13.39MM | $13.65MM |
| R&D Expense | $8.20MM | $8.44MM | $10.10MM |
| Income(Loss) | $-377.35MM | $45.03MM | $-101.89MM |
| Taxes | $-2.24MM | $0.65MM | $-1.77MM |
| Profit(Loss) | $-375.11MM | $44.38MM | $-100.12MM |
| Stockholders Equity | $302.30MM | $171.48MM | $59.39MM |
| Inventory | $35.26MM | $116.43MM | $91.32MM |
| Assets | $1,218.81MM | $1,008.91MM | $929.11MM |
| Operating Cash Flow | $-28.36MM | $-106.60MM | $21.75MM |
| Capital expenditure | $15.62MM | $17.39MM | $13.05MM |
| Investing Cash Flow | $-37.73MM | $-18.87MM | $-31.51MM |
| Financing Cash Flow | $959.03MM | $-205.24MM | $-37.45MM |
| Earnings Per Share* | $-3.67 | $0.30 | $-0.76 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.